Compounding Pharmacies Market (By Product: Oral, Parenteral, Rectal, Topical, Ophthalmic, Others; By Therapeutic Area: Pain Management, Hormone Replacement Therapies, Dermatological Applications, Nutritional Supplement, Others; By Sterility: Non-sterile, Sterile) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Compounding Pharmacies
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
   1.2.2. Compounding Pharmacies Market By Product
     1.2.2.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Product (2015-2026)
     1.2.2.2. Global Compounding Pharmacies Market Revenue Share By Product in 2018
     1.2.2.3. Oral
     1.2.2.4. Parenteral
     1.2.2.5. Rectal
     1.2.2.6. Topical
     1.2.2.7. Ophthalmic
     1.2.2.8. Others
   1.2.3. Compounding Pharmacies Market By Therapeutic Area
     1.2.3.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Therapeutic Area (2015-2026)
     1.2.3.2. Pain Management
     1.2.3.3. Hormone Replacement Therapies
     1.2.3.4. Dermatological Applications
     1.2.3.5. Nutritional Supplement
     1.2.3.6. Others
   1.2.4. Compounding Pharmacies Market By Sterility
     1.2.4.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Sterility (2015-2026)
     1.2.4.2. Non-sterile
     1.2.4.3. Sterile
   1.2.5. Compounding Pharmacies Market By Geography
     1.2.5.1. Global Compounding Pharmacies Market Revenue and Growth Rate Comparison By Geography (2015-2026)
     1.2.5.2. North America Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
     1.2.5.3. Europe Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
     1.2.5.4. Asia-Pacific Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
     1.2.5.5. Latin America Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Compounding Pharmacies Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Compounding Pharmacies Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Compounding Pharmacies Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Compounding Pharmacies Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Compounding Pharmacies Major Manufacturers in 2018

CHAPTER 4. COMPOUNDING PHARMACIES MARKET BY PRODUCT
4.1. Global Compounding Pharmacies Revenue By Product
4.2. Oral
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Parenteral
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Rectal
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Topical
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)\
4.6. Ophthalmic
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
   4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA
5.1. Global Compounding Pharmacies Revenue By Therapeutic Area
5.2. Pain Management
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hormone Replacement Therapies
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Dermatological Applications
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Nutritional Supplement
   5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
   5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. COMPOUNDING PHARMACIES MARKET BY STERILITY
6.1. Global Compounding Pharmacies Revenue By Sterility
6.2. Non-sterile
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Sterile
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
7.1. North America Compounding Pharmacies Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Compounding Pharmacies Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE COMPOUNDING PHARMACIES MARKET BY COUNTRY
8.1. Europe Compounding Pharmacies Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY COUNTRY
9.1. Asia-Pacific Compounding Pharmacies Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
10.1. Latin America Compounding Pharmacies Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA COMPOUNDING PHARMACIES MARKET BY COUNTRY
11.1. Middle East & Africa Compounding Pharmacies Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Compounding Pharmacies Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Therapeutic Area, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By Sterility, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. B. Braun Melsungen AG Company
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Cantrell Drug Company
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Dougherty’s Pharmacy
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Fagron
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. Fresenius Kabi AG.
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Mcguff compounding pharmacy services
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Institutional Pharmacy Solutions
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. ITC Compounding Pharmacy
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. PharMEDium Services LLC
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Others
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Type Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope